nivolumab,rp-1
replimune,bms
['ignyte', 'rp1', 'melanoma', 'nivo', 'nivolumab', '$repl', 'replimune', 'tyme']
$repl is in edinburgh for s 19th international congress! we ll be presenting data from the ongoing phase 1/2 clinical trial of rp1 combined with nivolumab (ignyte) in patients with #melanoma. 
Providing the 'on' switch for immuno-oncology